Needham Starts Clover Health at Buy, $6 Target; Shares Rise 4%
Needham launched Clover Health (CLOV) with a Buy rating and $6 target, citing cohort economics, Clover Assistant and a five-star PPO rating; shares rose 4% Wednesday.
Topic
Topic
Needham launched Clover Health (CLOV) with a Buy rating and $6 target, citing cohort economics, Clover Assistant and a five-star PPO rating; shares rose 4% Wednesday.
Citadel Securities and Wolfe Research have announced a joint venture, linking the market-making giant with the boutique research…
South Korea will require brokerages to devote 25% of analyst coverage to small caps and will let analysts publish sell ratings an…